Treace Medical Concepts (Treace Medical Concepts) Cash per Share : $1.78 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Treace Medical Concepts Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Treace Medical Concepts's Cash per Share for the quarter that ended in Mar. 2024 was $1.78.

Treace Medical Concepts Cash per Share Historical Data

The historical data trend for Treace Medical Concepts's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treace Medical Concepts Cash per Share Chart

Treace Medical Concepts Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

0.28

0.36

1.95

1.46

2.00

Treace Medical Concepts Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash per Share	Get a 7-Day Free Trial													2.79	2.27	1.98	2.00	1.78

Treace Medical Concepts Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Treace Medical Concepts's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	123.198	/	61.7
	=	2.00

Treace Medical Concepts's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	110.006	/	61.9
	=	1.78

Treace Medical Concepts (NAS:TMCI) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Treace Medical Concepts Cash per Share Related Terms

Thank you for viewing the detailed overview of Treace Medical Concepts's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Treace Medical Concepts (Treace Medical Concepts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Treace Medical Concepts Inc (NAS:TMCI) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081

Website

https://www.treace.com

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Executives

F Barry Bays	director
Betsy Hanna	director	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sean F. Scanlan	officer: See Remarks	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
James T Treace	director	117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082
Richard W Mott	director	1221 CROSSMAN AVENUE, SUNNYVALE CA 94089
Thomas E Timbie	director
Daniel E. Owens	officer: Chief HR Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Scot Michael Elder	officer: *See "Remarks"	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Mark Hair	officer: Chief Financial Officer	C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134
Aaron Berutti	officer: Sr. VP, Sales	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
John T. Treace	director, 10 percent owner, officer: Chief Executive Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Lance A Berry	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jane E Kiernan	director	525 W ROSCOE, CHICAGO IL 60657
John R Treace	director	5677 AIRLINE RD, ARLINGTON VA 38002